# Clinical Evaluation of Copesilcup

> **NCT07530328** · NA · COMPLETED · sponsor: **WMAS SpA** · enrollment: 256 (actual)

## Conditions studied

- Catheter-Associated Infection

## Interventions

- **DEVICE:** PEGylated Silicone Urinary Catheter with Copper Nanoparticles (COPESILCUP)
- **DEVICE:** Control Device

## Key facts

- **NCT ID:** NCT07530328
- **Lead sponsor:** WMAS SpA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07530328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07530328, "Clinical Evaluation of Copesilcup". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07530328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*